CAS: 1802326-66-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Benzamide, 3-chloro-N-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]- REF: IN-DA0021T5CAS: 1802326-66-4 | 98% | To inquire | Mon 05 May 25 |
 | JNJ-63533054 REF: 54-BUP08108CAS: 1802326-66-4 | ≥98% | 288.00 €~1,390.00 € | Tue 06 May 25 |
 | JNJ-63533054 REF: TM-T3119CAS: 1802326-66-4 | 98.38% - 99.87% | 35.00 €~1,026.00 € | Mon 12 May 25 |
 | JNJ-63533054 REF: 3D-CXC32666CAS: 1802326-66-4 | Min. 95% | - - - | Discontinued product |
![Benzamide, 3-chloro-N-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-](https://static.cymitquimica.com/products/IN/thumb/DA0021T5.jpg)
Benzamide, 3-chloro-N-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-
CAS:1802326-66-4
Formula:
C17H17ClN2O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
316.7821
Ref: IN-DA0021T5
| 1g | To inquire | ||
| 5mg | 51.00 € | ||
| 10mg | 68.00 € | ||
| 50mg | 170.00 € | ||
| 100mg | 207.00 € | ||
| 250mg | 550.00 € |
Estimated delivery in United States, on Monday 5 May 2025
Ref: 54-BUP08108
| 25mg | 288.00 € | ||
| 50mg | 499.00 € | ||
| 100mg | 726.00 € | ||
| 500mg | 1,390.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
JNJ-63533054
CAS:1802326-66-4
JNJ-63533054 is a potent and selective agonist of hGPR139 with an EC50 = 16 nM.
Formula:
C17H17ClN2O2
Purity:
98.38% - 99.87%
Color and Shape:
Solid
Molecular weight:
316.78
Ref: TM-T3119
| 1mg | 35.00 € | ||
| 5mg | 66.00 € | ||
| 10mg | 89.00 € | ||
| 25mg | 185.00 € | ||
| 50mg | 329.00 € | ||
| 100mg | 487.00 € | ||
| 500mg | 1,026.00 € | ||
| 1mL*10mM (DMSO) | 74.00 € |
Estimated delivery in United States, on Monday 12 May 2025
JNJ-63533054
CAS:1802326-66-4
JNJ-63533054 is a selective non-peptidic, opioid receptor antagonist that blocks the binding of opioids to …
Formula:
C17H17ClN2O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
316.78 g/mol
Ref: 3D-CXC32666
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
